Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
80.28
+3.39 (4.41%)
At close: Nov 13, 2026, 4:00 PM EST
81.22
+0.94 (1.17%)
After-hours: Nov 13, 2026, 7:30 PM EST
Tarsus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $110 | Buy | Maintains | $110 | +37.02% | Nov 11, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $94 → $102 | Buy | Maintains | $94 → $102 | +27.06% | Nov 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $89 → $97 | Buy | Reiterates | $89 → $97 | +20.83% | Nov 5, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 4, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 → $103 | Buy | Maintains | $100 → $103 | +28.30% | Nov 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $88 → $106 | Buy | Reiterates | $88 → $106 | +32.04% | Nov 4, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $116 | Buy | Initiates | $116 | +44.49% | Sep 24, 2026 |
| Jefferies | Jefferies | Buy Reiterates $105 | Buy | Reiterates | $105 | +30.79% | Sep 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.